Renal transplantation following previous heart, liver, and lung transplantation: An 8-year single-center experience

Surgery

Volumn 130, Issue 3, 2001, Pages 457-462

  Coopersmith, C M ^a   Brennan, D C ^a   Miller, B ^a   Wang, C ^a   Hmiel, P ^a   Shenoy, S ^a   Ramachandran, V ^a   Jendrisak, M D ^a   Ceriotti, C S ^a   Mohanakumar, T ^a   Lowell, J A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; TACROLIMUS;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CREATININE CLEARANCE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; PRIORITY JOURNAL; SURVIVAL RATE;

EID: 0034829185     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2001.115834     Document Type: Article

References (34)

1. Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy
2. Cyclosporine-associated chronic nephropathy
3. The long-term course of cyclosporine-associated chronic nephropathy
4. Chronic injury of human renal microvessels with low-dose cyclosporine therapy
5. Cyclosporine nephrotoxicity in lung transplant recipients
6. The incidence of renal failure in one hundred consecutive heart-lung transplant recipients
7. Treatment of end-stage renal failure after heart transplantation
8. Experience of end stage renal failure in 15 years of heart transplantation
9. Cyclosporine-associated end-stage nephropathy after cardiac transplantation
10. Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients
11. Long-term effects of cyclosporine on renal function in liver transplant recipients
12. Adverse effects of cyclosporine therapy following liver transplantation
13. Renal insufficiency and hypertension as long-term complications in liver transplantation
14. Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK 506
15. Long-term survival and renal function following liver transplantation in patients without hepatorenal syndrome - Experience in 300 patients
16. Renal outcomes in pediatric liver transplantation
17. Renal failure in children with hepatic failure undergoing liver transplantation
18. Cyclosporine nephrotoxicity in cardiac allograft patients - A seven-year follow-up
19. Cyclosporine-induced chronic nephropathy: An obliterative microvascular renal injury
20. Time course of decline in renal function in cyclosporine-treated heart transplant recipients
21. Early and late forms of cyclosporine toxicity: Studies in cardiac transplant recipients
22. Cyclosporine nephrotoxicity
23. Long-term survivors of pediatric heart transplantation: A multicenter report of sixty-eight children who have survived longer than five years
24. Risks and costs of end-stage renal disease after heart transplantation
25. A multilocular B-cell neoplasia presenting as multiple myeloma and polymorphic lymphoma of recipient origin 2 months after kidney transplantation in a heart-transplant recipient
26. Patterns of malignancies following renal transplantation
27. A randomized, double-blind comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients
28. Cyclosprin-nephrotoxicity following cardiac transplantation
29. Mechanisms of cyclosporine-induced nephrotoxicity
30. Kidney pathology in liver allograft recipients after long-term treatment with cyclosporin A
31. The kidney in liver transplantation
32. Renal function and morphology in cyclosporin A-treated liver transplant recipients